Consequently, a link between clinical efficiency and PD-L1 expression, CD8+ T cell tumor infiltration and somatic burden, or the number of neo-antigens originating from increased mutated genes and abnormal proteins has been proposed (131). Here, CD8A is linked to neoplasm.